| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/11/2005 | US20050175651 Oil core; shell covering of noncrosslinked polymer which is water insoluble and oil insoluble; encapsulated nanocapsules; cosmetics, drugs |
| 08/11/2005 | US20050175647 Compositions for topical application having androgenic actions |
| 08/11/2005 | US20050175644 Preparation for oxidation-sensitive compounds and method for making same |
| 08/11/2005 | US20050175642 Stable loratadine spill resistant formulation |
| 08/11/2005 | US20050175641 Homogenous liquid blend of hydrophilic polyvinyl alcohol, hydroxypropylmethyl cellulose, hydroxypropyl cellulose , polyvinyl pyrollidone, carbomer, maleic anhydride-methyl vinyl ether decadiene cross polymer and/or hydroxypropylguar; and hydrophobic ethyl cellulose; anti-onychomycoses agents; acne |
| 08/11/2005 | US20050175636 Containing stabilized neurotoxin as analgesic and skin penetration enhancing agent; inflammation and/or pain reduction |
| 08/11/2005 | US20050175631 Hiv vaccine and method of use |
| 08/11/2005 | US20050175629 Helicobacter pylori vaccination |
| 08/11/2005 | US20050175628 Chinese herb medicine composition in the form of jelly |
| 08/11/2005 | US20050175611 Storage stability, heat resistance; such as cetuximab combined with glycine and polyoxyethylene sorbitan monooleate in aqueous pH 5.5 citrate buffer |
| 08/11/2005 | US20050175603 Reduced-viscosity concentrated protein formulations |
| 08/11/2005 | US20050175592 Storage stability; use of bulking agents, cryoprotectants and lyoprotectants imparts desired properties that allow both lyophilized and liquid adenovirus formulations to be stored at 4 degrees C. for up to 6 months and retain an infectivity between 60-100% of the starting infectivity |
| 08/11/2005 | US20050175583 Making vector compositions that mimic the functionality of components of the immune system especially antigen-presenting cell (APC) element of the immune synapse; vaccination |
| 08/11/2005 | US20050175573 terblock polymer of ethylene oxide-propylene oxide-ethylene oxide terminated via carbamate or urea bond formed by mono or diisocyanate compounds; chain extesion; cosmetic, prosthetic inserted into an organ of human body; reversible gelation |
| 08/11/2005 | US20050175572 water-soluble copolymer obtained by radical copolymerization of acrylamide and/or methacrylamide and other water-soluble alpha, beta -ethylenically unsaturated compounds which are copolymerizable therewith; cosmetics, medicine, soaps, cream, lotion, hair shapmpoo, conditioner |
| 08/11/2005 | US20050175571 Prepared by melt processing a hydrophobic polymer includes repeating pyrrolidone/alkylene groups containing 10 or more carbon atoms, a hydrophilic polymer including polyacrylic acid, maleic acid-methyl vinyl ether copolymer, starch, cellulose, polyvinyl alcohol, dextrans/yclodextrin; cosmetics; skin |
| 08/11/2005 | US20050175565 Use of taurine for the treatment of alopecia |
| 08/11/2005 | US20050175549 Novel combination of anticholinergic and ss mimetics for the treatment of respiratory diseases |
| 08/11/2005 | US20050175547 Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases |
| 08/11/2005 | US20050175546 By loading sterile active ingredient into turboemulsifier through turbine after applying vacuum rather than loading it from top at atmospheric pressure, far more efficient dispersal of active ingredient, and therefore homogenous suspensions with a reproducible distribution can be obtained |
| 08/11/2005 | US20050175545 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
| 08/11/2005 | US20050175544 Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
| 08/11/2005 | US20050175541 Enhanced drug delivery |
| 08/11/2005 | US20050172954 Methods and systems for operating an aerosol generator |
| 08/11/2005 | US20050172578 Providing a packaged cosmetic device comprisig a preformed sheet and a coating of a skin benefiting agent by the continuous line process of applying eht coating in the unsealed package, placing the sheet in the package and sealing; industrial scale; also used for food processing and drug delivery |
| 08/11/2005 | DE202005007961U1 Composition containing at least one plant, animal or mineral medicament in homeopathic dosage useful for oral treatment of human and animal conditions and also for external treatment, e.g. of eczema |
| 08/11/2005 | DE202005004661U1 Composition containing tiotropium, useful for treatment of respiratory diseases by inhalation, comprises a dry powder filled directly into a sealed container |
| 08/11/2005 | DE202004020433U1 Capsule for investigation and treatment of the digestive tract comprises a housing which completely surrounds a permanent magnet, and incorporates at least one space for at least one medicament |
| 08/11/2005 | DE102004032781A1 New lipid-modified bis-phosphonic acid derivatives, useful e.g. for transporting therapeutic or diagnostic agents, with affinity for bone, also as corrosion inhibitors |
| 08/11/2005 | DE102004028415B4 Dermales oder transdermales therapeutisches System enthaltend eine Abdeckfolie mit Barrierewirkung The dermal or transdermal therapeutic system comprising a cover sheet with barrier effect |
| 08/11/2005 | DE102004004394A1 Mikroemulsion Microemulsion |
| 08/11/2005 | DE102004004202A1 Preparing enzyme granules, useful in nutritional, cleaning and pharmaceutical compositions, by spraying enzyme solution into gas stream containing solid particles, followed by drying and granulation |
| 08/11/2005 | DE102004001607A1 Neue Arzneimittelkombinationen auf der Basis von Scopin- oder Tropensäureestern mit EGFR-Kinase-Hemmern New drug combinations on the basis of scopine or tropical acid esters with EGFR kinase inhibitors |
| 08/11/2005 | CA2609888A1 Polyphenols as an intravesical agent for the prevention of transitional cell tumor implantation |
| 08/11/2005 | CA2554994A1 Haemostatic sprays and compositions |
| 08/11/2005 | CA2554959A1 Combination of a nmda receptor antagonist and a mao-inhibitor or a gadpf-inhibitor for the treatment of central nervous system-related conditions |
| 08/11/2005 | CA2554489A1 Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis |
| 08/11/2005 | CA2554424A1 Controlled and sustained delivery of nucleic acid-based therapeutic agents |
| 08/11/2005 | CA2554246A1 Nanosuspensions of anti-retroviral agents for increased central nervous system delivery |
| 08/11/2005 | CA2554243A1 Dermatologic soft gel compositions |
| 08/11/2005 | CA2554064A1 Treatment methods |
| 08/11/2005 | CA2553866A1 Treatment of degenerative cartilage conditions in a mammal with glycosi dase inhibitors |
| 08/11/2005 | CA2553657A1 Microcapsule with controllable or delayed release for immobilizing chemical and/or biological material in addition to method for the production thereof |
| 08/11/2005 | CA2553392A1 Sublingual drug delivery device |
| 08/11/2005 | CA2553390A1 Vaginal compositions for treating infections |
| 08/11/2005 | CA2551833A1 Liquid supplement compositions comprising one or more medicaments |
| 08/11/2005 | CA2548992A1 Immunotherapy compositions, method of making and method of use thereof |
| 08/11/2005 | CA2540308A1 Drug coating providing high drug loading and methods for providing the same |
| 08/10/2005 | EP1561760A2 Low molecular weight heparin salt with thriethanolamine |
| 08/10/2005 | EP1561472A1 Solid preparation |
| 08/10/2005 | EP1561463A2 Benzamidoxime prodrugs as antipneumocystic agents |
| 08/10/2005 | EP1561461A2 Adhesive mixture for transdermal delivery of highly plasticizing drugs |
| 08/10/2005 | EP1561460A1 Nanoparticles for the administration of active ingredients, method of producing said particles and composition containing same |
| 08/10/2005 | EP1561459A1 Pharmaceutical hard capsule containing inorganic substance |
| 08/10/2005 | EP1561458A1 Rapidly disintegrable solid preparation |
| 08/10/2005 | EP1560850A2 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion |
| 08/10/2005 | EP1560621A2 Methods and systems for providing orthogonally redundant monitoring in a sedation and analgesia sytem |
| 08/10/2005 | EP1560611A1 Self-folding polymer microparticles |
| 08/10/2005 | EP1560608A1 Moisture-activated adhesives for medical applications |
| 08/10/2005 | EP1560586A1 The use of an anti-allergy agent and a steroid to treat allergic rhinitis |
| 08/10/2005 | EP1560585A1 Dosage form that is safeguarded from abuse |
| 08/10/2005 | EP1560577A2 Pharmaceutical compositions and methods of using taxane derivatives |
| 08/10/2005 | EP1560572A1 Topical parasiticide formulations and methods of treatment |
| 08/10/2005 | EP1560571A2 Edible film for relief of cough or symptoms associated with pharyngitis |
| 08/10/2005 | EP1560570A1 Oral products containing novel flavor composition |
| 08/10/2005 | EP1560569A1 Gastro-retentive levodopa delivery form |
| 08/10/2005 | EP1560568A1 Controlled release pharmaceutical compositions containing sodium alginate and sodium calcium alginate |
| 08/10/2005 | EP1560567A1 Inhalation compositions with high drug ratios |
| 08/10/2005 | EP1560566A1 Controlled and continued delivery of rifaximin and/or other substances |
| 08/10/2005 | EP1560564A1 Multi-layer transmucosal therapeutic system |
| 08/10/2005 | EP1560563A1 Implantable medical device for controlled release of a substance |
| 08/10/2005 | EP1560562A2 Dermastick thickened ointment |
| 08/10/2005 | EP1560498A2 Chewing gum compositions with encapsulated stain removing agent |
| 08/10/2005 | EP1507514A4 Controlled release compositions of estradiol metabolites |
| 08/10/2005 | EP1471919B1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist |
| 08/10/2005 | EP1409140B1 Drug activation process with a vibrational mill |
| 08/10/2005 | EP1385552A4 Oral delivery method and composition for solid medications or dietary supplements |
| 08/10/2005 | EP1324760A4 Creatine ester pronutrient compounds and formulations |
| 08/10/2005 | EP1303257B1 Method of preparing a liquid unit dosage form and a kit |
| 08/10/2005 | EP1289740B1 Crystalline polymeric compositions for ophthalmic devices |
| 08/10/2005 | EP1282447A4 Stable polymeric micelle-type drug composition and method for the preparation thereof |
| 08/10/2005 | EP1228028B1 Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders |
| 08/10/2005 | EP1210092A4 Calcium-containing structures and methods of making and using the same |
| 08/10/2005 | EP1089710B1 Injectable pharmaceutical formulations of partricin derivatives |
| 08/10/2005 | EP1068306B1 Pentaerythritol lipid derivatives |
| 08/10/2005 | EP1051189B1 Vaccine formulation comprising sugar-alcohols and low concentrations of anorganic ions |
| 08/10/2005 | EP1003898B1 Integrin-targeting vectors having transfection activity |
| 08/10/2005 | EP0973605B1 Heat resistant lipid vesicles |
| 08/10/2005 | EP0971704B2 Comestible capsules having flavoured coatings |
| 08/10/2005 | EP0954284B1 Solid lipid compositions of lipophilic compounds for enhanced oral bioavailability |
| 08/10/2005 | EP0927036B9 Transdermal therapeutical approach involving a combination of bisphosphate containing oestriol |
| 08/10/2005 | EP0894009B1 Improved vision through photodynamic therapy of the eye |
| 08/10/2005 | EP0873096B1 Ophthalmic treatment |
| 08/10/2005 | EP0837883B1 Method of solubilizing, purifying, and refolding protein |
| 08/10/2005 | EP0794797B1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 08/10/2005 | CN2715753Y Combined transdermal cream for treating male impotence and premature ejaculation |
| 08/10/2005 | CN2715752Y 药片 Pill |
| 08/10/2005 | CN1653140A Capsules printed with sepia colored containing inks |
| 08/10/2005 | CN1653127A Modified polymeric films |
| 08/10/2005 | CN1653125A Amelioration of the development of cataracts and other ophthalmic diseases |